The short answer
Ginger powder may change average glucose control, but added hypoglycemia with insulin isophane has not been established. A glucose improvement in a diabetes trial does not by itself prove that interaction.
What this answer covers
Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols.
- Supplement or preparation
- Zingiber Officinale (Ginger) Root Powder
- Medication ingredient
- insulin isophane
The powder study measured glucose control
An eight-week trial tested ginger powder capsules and reported lower fasting glucose and HbA1c measures. It did not supply an insulin-isophane-specific treatment analysis.
The adverse outcome remains uncertain
Lower average glucose can be beneficial when glucose starts high. It is not the same as a documented episode of hypoglycemia. The inspected abstract does not establish a low-glucose event rate with glulisine.
Keep the preparation boundary
The trial used powder. Its dose cannot be treated as a safe threshold with insulin, and the findings do not cover every ginger extract or multi-ingredient diabetes product.
Keep the NPH treatment plan
Discuss the exact product and amount with the diabetes team before starting or stopping it. Follow your glucose-monitoring and low-glucose treatment plan. Do not adjust insulin yourself. NPH is an intermediate-acting subcutaneous suspension, not a rapid mealtime analog. Supplement spacing has no established protective effect.
Evidence and practical considerations
Side effects & toxicity
Indirect preparation-specific glucose evidence does not establish added clinical hypoglycemia with insulin isophane.
- Exact scope
- Dried Zingiber officinale rhizome powder, often sold as root powder; not all extracts, oils or isolated gingerols. with Insulin isophane RxCUI1605101 IN; human NPH subcutaneous suspension label bridge.
- Medication form and route
- subcutaneous insulin isophane; oral supplement
What remains uncertain
- No exact event rate or arbitrary dose adjustment.
Factors that may matter: Product; Dose; Meals; Other diabetes treatment.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 2: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed human NPH insulin
Hypoglycemia can be severe. Niacin may reduce glucose lowering. Changes in glucose-active treatments and meals can require monitoring and clinician review. Intravenous and pump use prohibited.
How this applies: RxCUI1605101 IN insulin isophane; human NPH formulation bridge explicit.
Human NPH labels inform the generic insulin-isophane ingredient. Not animal insulin, rapid analogs or automatically every premix. No herb-specific event rate.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 88participants with type 2 diabetes.
Ginger powder reduced fasting glucose and HbA1c measures relative to the study comparison; hypoglycemia rates not supplied.
How this applies: Indirect for exact insulin isophane; study drug, supplement form and outcome retained.
No glipizide-specific regimen or low-glucose adverse-event analysis in inspected abstract. Glucose improvement is not necessarily hypoglycemia. This does not establish an exact insulin-isophane interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Prepared exact isophane article with human NPH product bridge and source-specific clinical limits. | |
| Research summary published |
Article revision: 37eb08c10a6659cb
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.